01951.HK
Jinxin Fertility Group Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 2.24
−0.67%Oct 27, 2026, 00:56 UTC
Jinxin Fertility Group Ltd. repurchased 1.9675 million shares for approximately HK$4.4454 million at HK$2.235–HK$2.29 per share.
Source:Oct 26, 2026, 01:35 UTC
Jinxin Fertility Group Ltd. repurchased 2.5195 million shares on October 23 at HK$2.16–HK$2.23 per share, for approximately HK$5.5365 million.
Source:Oct 23, 2026, 01:13 UTC
Jinxin Fertility Group Ltd. repurchased 3.295 million shares on October 22 at HK$2.165–HK$2.24 per share, for approximately HK$7.1876 million.
Source:Sep 30, 2026, 01:13 UTC
Jinxin Fertility Group announced a plan to securitize a Shenzhen property held by its wholly-owned subsidiary Hengyu via an asset-backed securities (ABS) program on the Shanghai Stock Exchange, expecting to raise about RMB 1.93 billion.
Source:Sep 22, 2026, 00:53 UTC
Jinxin Fertility Group (01951.HK) repurchased 1.307 million of its own shares on September 21 at HK$2.13–2.15 per share for about HK$2.7973 million.
Source:Sep 10, 2026, 09:48 UTC
Jinxin Fertility Group signed a research cooperation memorandum with Professor Ji Weizhi to explore collaboration in reproductive and developmental biology, regenerative medicine, disease models and translational medicine, initially focusing on premature ovarian failure and diminished ovarian reserve.
Source:Aug 25, 2026, 23:48 UTC
Jinxin Fertility Group Limited repurchased 2.6575 million of its own shares on August 15, 2026, for a total of HK$5.9997 million, at prices ranging from HK$2.245 to HK$2.26 per share.
Source:Aug 21, 2026, 10:26 UTC
Jin Xin Fertility Group reported interim results for the six months ended June 2026, with revenue of RMB 1.373 billion, up 6.6% year-on-year, and a net profit of RMB 107 million, turning around from a loss of RMB 1.04 billion in the same period last year.
Source:Aug 13, 2026, 00:40 UTC
Jinxin Fertility launched its 'Fertility-Friendly Hundred Cities Tour' public welfare program in Chengdu, committing to invest resources worth 100 million yuan over three years to provide free IVF slots and fertility subsidies to eligible families.
Source:Aug 5, 2026, 02:42 UTC
Jinxin Fertility launched its self-developed AI agent 'IVF Co-pilot' for assisted reproduction clinical decision support, starting a pilot at Sichuan Jinxin Xinan Women and Children's Hospital.
Source:Jul 22, 2026, 01:37 UTC
Jinxin Fertility Group expects to turn a profit in the first half of 2026, with net profit of at least 90 million yuan.
Source: